OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director exercised or converted 2,720 UTHR derivative securities | OQRO

Home
Insider trades
United Therapeutics
Director exercised or converted 2,720 UTHR derivative securities

Insider trades

Insider trade

Director exercised or converted 2,720 UTHR derivative securities

Traded Dec 22, 2025 · Filed Dec 24, 2025

UTHUnited TherapeuticsUTHR

2,720
Shares · @ $229.81

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 22, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 24, 2025

DirectorIndirect holdingOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

0001193522-25-000004

Filed / recorded

Dec 24, 2025, 2:33 AM UTC

Added to OQRO

Oct 6, 2026, 9:34 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

UNITED THERAPEUTICS Corp

Issuer CIK

1082554

Ticker

UTHR

Reporting person

Louis W Sullivan

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Dec 22, 2025

Transaction code

Shares / units

2,720

Price per share

$229.81

Acquired / disposed

Acquired (A)

Shares owned after

5,950

Ownership form

Indirect — by Trust

Amendment

Footnotes from the filing

These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power.

Around the same time

Jan Malcolm (Director) sold ~$23K of United Therapeutics

Scheduled in advanceFiled 9mo ago

Paul A MahonEVP & GENERAL COUNSEL

Filed 9mo ago

8,300Shares · @ $146.03

Traded Jan 15 · filed 1 day later

Derivative exercise or conversion — not an open-market buy.

More Official record

Paul A Mahon (EVP & GENERAL COUNSEL) sold ~$674K of United Therapeutics

Scheduled in advanceFiled 9mo ago